Meeting Coverage:

American Academy of Ophthalmology

AAO: 2017

Who, What, Where, and When?

Show Description +

Ike Ahmed, MD, and Arsham Sheybani, MD, comment on the changing glaucoma space, noting the complexities of developing a treatment plan in this evolving environment of new information, evidence, and devices.

Posted: 11/18/2017

Up Next

An Update on GATT

Davinder Grover, MD


Who Should Perform MIGS?

Michael Patterson, DO

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Who Should Perform MIGS?

Osamah Saeedi, MD

Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD

Who, What, Where, and When?

Ike Ahmed, MD, and Arsham Sheybani, MD, comment on the changing glaucoma space, noting the complexities of developing a treatment plan in this evolving environment of new information, evidence, and devices.

Posted: 11/18/2017


Please log in to leave a comment.

More From AAO: 2017 Coverage

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD